Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Mathieu Bibian
Introduction
Mathieu Bibian is a notable inventor based in Creissels, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on Wee1 degradation inhibitors. His research focuses on developing compounds that can inhibit the degradation of Wee1, which has important implications for treating various medical conditions.
Latest Patents
Mathieu Bibian holds a patent for his invention titled "Wee1 degradation inhibitors." This invention provides compounds that inhibit the degradation of Wee1. The compounds are generally classified as N-((1H-benzo[d]imidazol-2-yl)methyl)-9H-purin-6-amines. These compounds can be utilized for the treatment of conditions where inhibition of Wee1 is medically indicated, such as cancer, Alzheimer's disease, neurological disorders, psychiatric disorders, and inflammation-related disorders. He has 1 patent to his name.
Career Highlights
Throughout his career, Mathieu Bibian has worked with prestigious organizations, including The Scripps Research Institute and Æterna Zentaris GmbH. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Mathieu has collaborated with esteemed colleagues, including William R. Roush and Ronald Rahaim. These collaborations have enriched his research and fostered innovation in the field.
Conclusion
Mathieu Bibian's contributions to the field of medicinal chemistry, particularly through his patent on Wee1 degradation inhibitors, highlight his role as an influential inventor. His work has the potential to impact the treatment of various medical conditions significantly.